Solarcare Technologies Corp, Inc.
United StatesFDA applicant, unverified
- Devices
- 28
What Solarcare Technologies Corp, Inc. makes
Solarcare Technologies Corp, Inc. manufactures in-vitro diagnostic assays for clinical and drug screening, including micro-plate immunoassays for thyroid hormones (T4, TSH), urinary protein, creatinine, hemoglobin, leukocyte esterase, and benzodiazepines. Their portfolio also includes enzyme immunoassays (EIA) for detecting benzoylecgonine, methaqualone, opiates, and phencyclidine (PCP) in urine samples, designed for automated analysis systems.
The company’s devices are classified under FDA categories Class I, Class II, and Unclassified (U), with submissions recorded in the FDA’s 510(k) registry. Their products are listed under U.S. regulatory oversight and are intended for use in clinical laboratories and drug testing facilities.
Catalogue
Search and filter all 28 devicesFrequently asked questions
How many devices does Solarcare Technologies Corp, Inc. have in the registry?
The registry currently lists 28 devices for Solarcare Technologies Corp, Inc.. Devices recorded under merged duplicate company entries are counted once.
Which registries list Solarcare Technologies Corp, Inc.'s devices?
Among its 28 most recently registered devices, Solarcare Technologies Corp, Inc. has devices listed in FDA 510(k) (28 devices).
What risk classes do Solarcare Technologies Corp, Inc.'s devices fall under?
Among its 28 most recently registered devices, the classes recorded for Solarcare Technologies Corp, Inc.'s devices are Class I and Class II. Each device page shows its own class and authorisation.
What are the newest devices from Solarcare Technologies Corp, Inc. in the registry?
The most recently registered devices listed for Solarcare Technologies Corp, Inc. include NAT. SCREENING INSTITUTE MICRO-PLATE FREE T4 ASSAY, STC DIAGNOSTICS AUTO-LYTE URINARY HEMOGLOBIN ASSAY, STC DIAGNOSTICS AUTO-LYTE BENZODIAZEPINES EIA and STC DIAGNOSTICS AUTO-LYTE URINARY PROTEIN ASSAY.